PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma
Kirsi Toivanen(University of Helsinki), Harri Sihto(University of Helsinki)
Cited by 6
Related Papers
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
|Breast Cancer Research|2011|228
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
|British Journal of Cancer|2017|17
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses
|International Journal of Cancer|2023|12
Pharmacokinetic profile and <i>in vivo</i> anticancer efficacy of anagrelide administered subcutaneously in rodents
|Drug Delivery|2025|4
Phosphodiesterase 3A modulators sensitize tumor cells to Bcl-xL and Bcl-2/Bcl-xL inhibitors
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1